Show Health and Fitness Publications

Mon, February 6, 2012

[ Mon, Feb 06th 2012 ] - Market Wire

AltheaDx Certified as Authorized Customer Service Provider by Ion Torrent

[ Mon, Feb 06th 2012 ] - Market Wire

Biotech Leaders Wei-Wu He, Ph.D and Tak W. Mak, Ph.D Join EntreMed's Board of Directors

[ Mon, Feb 06th 2012 ] - Market Wire

EntreMed Completes Strategic Financing

[ Mon, Feb 06th 2012 ] - Market Wire

Soligenix Demonstrates Positive Proof of Concept .. roprietary Vaccine Thermostabilization Technology

[ Mon, Feb 06th 2012 ] - Market Wire

United Therapeutics Receives Paragraph IV Notice Letter for Remodulin

[ Mon, Feb 06th 2012 ] - Market Wire

SciClone Pharmaceuticals to Present at BIO CEO &;; Investor Conference

[ Mon, Feb 06th 2012 ] - Market Wire

Implant Sciences' Quantum Sniffer QS-B220 Bench-T .. Trace Detector Achieves ASTM E2520 Certification

[ Mon, Feb 06th 2012 ] - Market Wire

Adeona Announces Executive Management Transitions .. ntments to Strengthen Company's Synthetic Biologi

[ Mon, Feb 06th 2012 ] - Market Wire

BioLife Solutions Congratulates DCPrime on Its Ap .. Product Application for DCOnea" Leukemia Vaccine

[ Mon, Feb 06th 2012 ] - Market Wire

PAREXEL to Address Innovative Approaches to Late .. Development at Summit for Clinical Ops Executives

[ Mon, Feb 06th 2012 ] - Market Wire

Greystone Logistics Income Rises in Second Quarter on Improved Sales

[ Mon, Feb 06th 2012 ] - Market Wire

Inovio Pharmaceuticals to Present at BIO CEO amp;; Investor Conference

[ Mon, Feb 06th 2012 ] - Market Wire

Inovio Pharmaceuticals to Present at BIO CEO & Investor Conference

Sun, February 5, 2012

[ Sun, Feb 05th 2012 ] - Market Wire

Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE

[ Sun, Feb 05th 2012 ] - Market Wire

Sat, February 4, 2012

[ Sat, Feb 04th 2012 ] - Market Wire

SurModics Announces Rescheduled Webcast for First .. arter 2012 Earnings Conference Call on February 6

[ Sat, Feb 04th 2012 ] - Market Wire

Cigna Corporation Announces Appearance at the 22n .. Annual UBS Global Healthcare Services Conference

Fri, February 3, 2012

[ Fri, Feb 03rd 2012 ] - Market Wire

Brower Piven Files Class Action Suit Against GenVec, Inc.

[ Fri, Feb 03rd 2012 ] - Market Wire

Faruqi amp;; Faruqi, LLP Files Securities .. ina Medical Technologies, Inc. and Certain of Its

[ Fri, Feb 03rd 2012 ] - Market Wire

VentriPoint Announces Extension of Expiry Date of Warrants

[ Fri, Feb 03rd 2012 ] - Market Wire

MSA Schedules Fourth Quarter Earnings Webcast

[ Fri, Feb 03rd 2012 ] - Market Wire

Buyout Offer for Micromet Triggers Shareholder-Cl .. nvestigation by Goldfarb LLP Securities Attorneys

[ Fri, Feb 03rd 2012 ] - Market Wire

Universal Health Services, Inc. to Present at the 22nd Annual UBS Healthcare Services Conference

[ Fri, Feb 03rd 2012 ] - Market Wire

Insulet Corporation to Report Fourth Quarter and .. l Year 2011 Financial Results on February 9, 2012

[ Fri, Feb 03rd 2012 ] - Market Wire

Syneron to Present at the Leerink Swann 2012 Global Healthcare Conference

[ Fri, Feb 03rd 2012 ] - Market Wire

3SBio Inc. Schedules Unaudited Fourth Quarter and Full Year 2011 Results

[ Fri, Feb 03rd 2012 ] - Market Wire

Questcor Announces Preliminary Fourth Quarter and Full Year 2011 Net Sales and Operating Income

[ Fri, Feb 03rd 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights Stryker Corporation and Zimmer Holdings, Inc.

[ Fri, Feb 03rd 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights VIVUS, Inc. and Biogen Idec Inc.

[ Fri, Feb 03rd 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights Forest Laboratories, Inc. and SAP AG (ADR)

[ Fri, Feb 03rd 2012 ] - Market Wire

Endo Pharmaceuticals to Announce Fourth Quarter a .. Year 2011 Financial Results on February 24, 2012

[ Fri, Feb 03rd 2012 ] - Market Wire

PharmaGap In Vivo Study Results Include Indicatio .. Ascites, 62% Reduction In Tumour Burden in Ovaria

[ Fri, Feb 03rd 2012 ] - Market Wire

Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184

[ Fri, Feb 03rd 2012 ] - Market Wire

Genomic Health Presents Results Furthering Unders .. e Cancer at the 2012 Genitourinary Cancers Sympos

[ Fri, Feb 03rd 2012 ] - Market Wire

Aeterna Zentaris Reports Updated Phase 1 Trial Re .. ion- and Taxane-Resistant Prostate Cancer at ASCO

[ Fri, Feb 03rd 2012 ] - Market Wire

IRIDEX and Cutera Close Acquisition of IRIDEX' Aesthetic Business Unit

[ Fri, Feb 03rd 2012 ] - Market Wire

The Ensign Group Acquires Reno Assisted Living Facility

[ Fri, Feb 03rd 2012 ] - Market Wire

Threshold Pharmaceuticals and Merck KGaA Announce .. op and Commercialize Phase 3 Hypoxia-Targeted Dru

Thu, February 2, 2012

[ Thu, Feb 02nd 2012 ] - Market Wire

Solta Medical to Report Fourth Quarter 2011 Resul .. s Release and Host Conference Call on February 13

[ Thu, Feb 02nd 2012 ] - Market Wire

International Drug & Explosives Detection Company IDenta Corp. Targets New American Markets

[ Thu, Feb 02nd 2012 ] - Market Wire

Vista Partners Publishes February 2012 Newsletter

[ Thu, Feb 02nd 2012 ] - Market Wire

Pro-Dex, Inc. Announces Fiscal 2012 Second Quarter Financial Results Conference Call and Webcast

[ Thu, Feb 02nd 2012 ] - Market Wire

2012 Economic Outlook - Report Highlights Valeant .. aceuticals Int (USA) and The Dow Chemical Company

[ Thu, Feb 02nd 2012 ] - Market Wire

$30 Million Due to MMRGlobal Under Non-Exclusive Patent License Agreement

[ Thu, Feb 02nd 2012 ] - Market Wire

OncoSec's President and CEO Explains His Firm's Ambitious List of Milestones for 2012

[ Thu, Feb 02nd 2012 ] - Market Wire

CryoLife Announces Release Date and Teleconferenc .. 011 Fourth Quarter and Year End Financial Results

[ Thu, Feb 02nd 2012 ] - Market Wire

AVI BioPharma to Present Company Overview at the .. Annual BIO CEO &;; Investor Conference

[ Thu, Feb 02nd 2012 ] - Market Wire

Equity Research on Amgen Inc. and Biogen Idec Inc. - Biotech Industry Growing

[ Thu, Feb 02nd 2012 ] - Market Wire

The Methodist Hospital to Pioneer Vascular Research With Hansen Medical Vascular Robotic System

[ Thu, Feb 02nd 2012 ] - Market Wire

Cytomedix Announces Option Extension With Top 20 .. and Intent to Proceed to License Agreement for t

[ Thu, Feb 02nd 2012 ] - Market Wire

YouTube Interview Now Available for Kedem Pharmac .. i Updating Company Progress on Sublingual Drug De

[ Thu, Feb 02nd 2012 ] - Market Wire

Discovery Labs Cleared to Market AFECTAIR in U.S.

[ Thu, Feb 02nd 2012 ] - Market Wire

Horizon Pharma to Present at the 14th Annual BIO CEO and Investor Conference

[ Thu, Feb 02nd 2012 ] - Market Wire

Mylan Receives Tentative FDA Approval for Generic Version of Lipitor

[ Thu, Feb 02nd 2012 ] - Market Wire

Warnex Extends Maturity Date of Its Outstanding Debenture

[ Thu, Feb 02nd 2012 ] - Market Wire

Nuvo Research announces launch of Synera in the U.S.

[ Thu, Feb 02nd 2012 ] - Market Wire

Syneron Announces New Ground Breaking evolastina" Procedure

[ Thu, Feb 02nd 2012 ] - Market Wire

Delcath Announces First European Chemosat Procedures

Wed, February 1, 2012

[ Wed, Feb 01st 2012 ] - Market Wire

LifeSci Advisors Announces Investment Opinion on Repligen Corporation

[ Wed, Feb 01st 2012 ] - Market Wire

Critical Alerts For Merck, Best Buy, Lorillard, E .. m Creek Timber Released By Seven Summits Research

[ Wed, Feb 01st 2012 ] - Market Wire

Cyberonics to Report Fiscal Year 2012 Third Quart .. lts and Host Conference Call on February 24, 2012

[ Wed, Feb 01st 2012 ] - Market Wire

AspenBio Sets 2012 AppyScore Anticipated Mileston .. ical Trial for Appendicitis Test Beginning Mid-20

[ Wed, Feb 01st 2012 ] - Market Wire

Ardea Biosciences Prices Public Offering of Common Stock

[ Wed, Feb 01st 2012 ] - Market Wire

Valeant Pharmaceuticals Acquires Probiotica in Brazil

[ Wed, Feb 01st 2012 ] - Market Wire

Daxor Announces That Shertech Pharmacy Corp. Acqu .. ood Volume Analyzer to Service Multiple Hospitals

[ Wed, Feb 01st 2012 ] - Market Wire

Abbott to Present at Leerink Swann 2012 Global Healthcare Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Boston Scientific Announces First Implant and Mar .. h of PROMUS Elementa" Plus Stent System in Europe

[ Wed, Feb 01st 2012 ] - Market Wire

Pfizer and GlaxoSmithKline Optimistic on Growth Prospects

[ Wed, Feb 01st 2012 ] - Market Wire

New Revenues Drivers From Eli Lilly and AstraZeneca Poised to Offset Patent Cliffs

[ Wed, Feb 01st 2012 ] - Market Wire

AMRI CFO to Present at UBS 22nd Annual Global Healthcare Services Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Aethlon Medical Reports Immediate and Rapid Virol .. C (HCV) Patients Receiving Hemopurifier Treatment

[ Wed, Feb 01st 2012 ] - Market Wire

Shire and Sangamo Collaborate to Develop Therapeu .. atment of Hemophilia and Other Monogenic Diseases

[ Wed, Feb 01st 2012 ] - Market Wire

Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference

[ Wed, Feb 01st 2012 ] - Market Wire

Implant Sciences' Quantum Sniffer QS-H150 Securit .. to Major Oil Corporation for Deployment in Africa

[ Wed, Feb 01st 2012 ] - Market Wire

Savient Pharmaceuticals Appoints David Y. Norton Interim Chief Executive Officer

[ Wed, Feb 01st 2012 ] - Market Wire

OncoSec President and CEO Contributes to Physicians News Digest

[ Wed, Feb 01st 2012 ] - Market Wire

PAREXEL and ASAN Medical Center Establish Allianc .. d Drug Development and Commercialization Programs

[ Wed, Feb 01st 2012 ] - Market Wire

Concord Medical Services Holdings Limited Engages .. p LLC to Establish a Strategic Investor Relations

Tue, January 31, 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Generex Announces $2.00 Million Capital Investment

[ Tue, Jan 31st 2012 ] - Market Wire

KineMed annuncia di aver stretto una collaborazio .. per lo sviluppo di approcci innovativi al trattam

[ Tue, Jan 31st 2012 ] - Market Wire

Hospira ernennt Richard Davies zum Chief Commercial Officer

[ Tue, Jan 31st 2012 ] - Market Wire

First Case in VISIUS Surgical Theatre at Florida Hospital

[ Tue, Jan 31st 2012 ] - Market Wire

Exactech Announces Preliminary 2011 Sales of $205 .. llion and 4th Quarter 2011 Sales of $53.1 Million

[ Tue, Jan 31st 2012 ] - Market Wire

Patient Home Monitoring (PHM) Announces Audited F .. cal Quarter 2012 Results and Anticoagulation Clin

[ Tue, Jan 31st 2012 ] - Market Wire

[ Tue, Jan 31st 2012 ] - Market Wire

Dendreon, Delta Air Lines, JDS Uniphase

[ Tue, Jan 31st 2012 ] - Market Wire

Health Netas & UCLAas Health Literacy Social Media Program Opens to All Teens Nationwide

[ Tue, Jan 31st 2012 ] - Market Wire

Community Health Systems Announces Execution of A .. ate with Longview, Texas, Multi-Speciality Clinic

[ Tue, Jan 31st 2012 ] - Market Wire

Catasys Contracts With Coventry Health Care of Oklahoma

[ Tue, Jan 31st 2012 ] - Market Wire

Shares of BioSante and Cell Therapeutics on the Upswing as Biotech Sector Rallies

[ Tue, Jan 31st 2012 ] - Market Wire

Biomerica Launches New Patented Test to Identify .. eloping Severe Side Effects From Thiopurine Drugs

[ Tue, Jan 31st 2012 ] - Market Wire

West to Present at UBS Conference

[ Tue, Jan 31st 2012 ] - Market Wire

Life Technologies Names Alan Sachs as Head of Global Research and Development

[ Tue, Jan 31st 2012 ] - Market Wire

AcelRx Announces its ARX-01 Phase 3 Program Expected to Start Late Q1 or Early Q2 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Biogen Idec nombra a Kenneth DiPietro Vicepresidente ejecutivo de Recursos Humanos

[ Tue, Jan 31st 2012 ] - Market Wire

Reflect Scientific, Inc. Has Positive Outlook for 2012

[ Tue, Jan 31st 2012 ] - Market Wire

Inovio Pharmaceuticals Moves Closer to "Universal .. trating Protective Immune Responses Against Multi

[ Tue, Jan 31st 2012 ] - Market Wire

Inovio Pharmaceuticals Moves Closer to quot;&# .. luenza Vaccine by Demonstrating Protective Immune

Mon, January 30, 2012

[ Mon, Jan 30th 2012 ] - Market Wire

Greatbatch, Inc. to Participate in the 2012 Canaccord Genuity Musculoskeletal Conference

[ Mon, Jan 30th 2012 ] - Market Wire

Watson Announces New Jersey-Based Global Ramp;;D Technology Center

[ Mon, Jan 30th 2012 ] - Market Wire

ISTA's Board Reiterates Commitment to Maximizing .. hareholder Value Through Strategic Review Process

[ Mon, Jan 30th 2012 ] - Market Wire

AMAG Pharmaceuticals Announces Completion of Enro .. am Evaluating Feraheme for a Broader Iron Deficie

[ Mon, Jan 30th 2012 ] - Market Wire

Allos Therapeutics Requests Re-Examination of CHM .. FOLOTYN in PTCL at the European Medicines Agency

[ Mon, Jan 30th 2012 ] - Market Wire

Alnylam Receives Notice of Allowance from United .. ffice (USPTO) for New Patent Broadly Covering Sec

[ Mon, Jan 30th 2012 ] - Market Wire

Biogen Idec Appoints Kenneth DiPietro Executive Vice President, Human Resources

[ Mon, Jan 30th 2012 ] - Market Wire

Community Health Systems, Inc. Finalizes Amendment and Extension of Its Credit Facilities

[ Mon, Jan 30th 2012 ] - Market Wire

Kenneth DiPietro kommt als Executive Vice President, Human Resources zu Biogen Idec

[ Mon, Jan 30th 2012 ] - Market Wire

Valeant Pharmaceuticals Withdraws Offer for Acquisition of ISTA Pharmaceuticals Inc.

[ Mon, Jan 30th 2012 ] - Market Wire

Revaskularisierungsgert von Covidien zur interven .. llen Behandlung bei Schlaganfallstudie zugelassen

[ Mon, Jan 30th 2012 ] - Market Wire

Compugen Presents Three Product Candidates for Tr .. s at the Immunotherapeutics & Immunomonitoring Co

[ Mon, Jan 30th 2012 ] - Market Wire

Dispositivo per la rivascolarizzazione di Covidie .. tazione interventistica sulla gestione dell'ictus

[ Mon, Jan 30th 2012 ] - Market Wire

Implant Sciences Sells Explosives Trace Detection Units for Deployment in Africa

[ Mon, Jan 30th 2012 ] - Market Wire

Covidien Revascularization Device Approved for Interventional Management of Stroke Trial

[ Mon, Jan 30th 2012 ] - Market Wire

Le dispositif de revascularisation Covidien appro .. essai visant la gestion interventionnelle des AVC

[ Mon, Jan 30th 2012 ] - Market Wire

Synageva BioPharma Highlights Key Data Presentati .. g Lysosomal Disease Network (LDN) World Symposium

[ Mon, Jan 30th 2012 ] - Market Wire

DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases

[ Mon, Jan 30th 2012 ] - Market Wire

Capital Senior Living Corporation to Present at U .. are Services Conference on Wednesday, February 8,

[ Mon, Jan 30th 2012 ] - Market Wire

Wright Medical Group, Inc. Names Daniel Garen Senior Vice President and Chief Compliance Officer

Sat, January 28, 2012

[ Sat, Jan 28th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Health Management Associates, Inc.

[ Sat, Jan 28th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of Micromet, Inc.

Fri, January 27, 2012

[ Fri, Jan 27th 2012 ] - Market Wire

Medisafe 1 Technologies Announces $1MM Stock Repu .. ase Program of 10MM Shares up to 10 Cents a Share

[ Fri, Jan 27th 2012 ] - Market Wire

Bionovo to Voluntarily Delist from NASDAQ

[ Fri, Jan 27th 2012 ] - Market Wire

Brower Piven Encourages Investors Who Have Losses .. nvestment in TranS1, Inc. to Inquire About the Le

[ Fri, Jan 27th 2012 ] - Market Wire

Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash

[ Fri, Jan 27th 2012 ] - Market Wire

Illuminaas Board of Directors to Review Unsolicited Tender Offer from Roche

[ Fri, Jan 27th 2012 ] - Market Wire

ZOLL Medical, Vistaprint NV, Corning, Apple and Google

[ Fri, Jan 27th 2012 ] - Market Wire

BIOLASE Signs Strategic Sales and Marketing Partn .. udy Club, a Leading Dental Education Organization

[ Fri, Jan 27th 2012 ] - Market Wire

Medtronic Launches New Minimally Invasive Cardiac .. lusive Distribution Agreement with Miami Instrume

[ Fri, Jan 27th 2012 ] - Market Wire

Boston Scientific, Sirius, Momenta Pharmaceuticals, Gran Tierra Energy, Taseko Mines and TiVo

[ Fri, Jan 27th 2012 ] - Market Wire

Reduce Stress and Help Shoo the Flu

[ Fri, Jan 27th 2012 ] - Market Wire

Centene Corporation to Present at UBS 2012 Healthcare Conference

[ Fri, Jan 27th 2012 ] - Market Wire

CooperVisiona" Helps the Association for the Blind and Visually Impaired

[ Fri, Jan 27th 2012 ] - Market Wire

Tornier Announces 2011 Fourth Quarter and Full Year Conference Call

[ Fri, Jan 27th 2012 ] - Market Wire

WellPoint Launches Innovative Reimbursement Initi .. y Care Physicians to Improve Quality and Reduce M

[ Fri, Jan 27th 2012 ] - Market Wire

GenVec Extends Research Collaboration with Global Pharmaceutical Company

[ Fri, Jan 27th 2012 ] - Market Wire

iBio, Inc. Listing Deficiency Resolved

[ Fri, Jan 27th 2012 ] - Market Wire

Infinity Reports Update from Phase 2 Study of Sar .. ine in Patients with Metastatic Pancreatic Cancer

[ Fri, Jan 27th 2012 ] - Market Wire

El estudio ASCEND evaluar la eficacia de TYSABRI .. o para la esclerosis mltiple secundaria progresiv

[ Fri, Jan 27th 2012 ] - Market Wire

Independent Data Published on BioLife Solutions HypoThermosol and CryoStor

[ Fri, Jan 27th 2012 ] - Market Wire

Dr. Reddyas Clarifies Media Reports

Thu, January 26, 2012

[ Thu, Jan 26th 2012 ] - Market Wire

Aetna Announces Transaction with Vitality Re III

[ Thu, Jan 26th 2012 ] - Market Wire

Theratechnologies to Announce Results for Its 2011 Fiscal Year

[ Thu, Jan 26th 2012 ] - Market Wire

Vista Partners Updates Coverage on OncoSec Medical Inc.;; Target Price $2.50

[ Thu, Jan 26th 2012 ] - Market Wire

Align Technology, Zeltiq Aesthetics & Others

[ Thu, Jan 26th 2012 ] - Market Wire

Align Technology, Zeltiq Aesthetics amp;; Others

[ Thu, Jan 26th 2012 ] - Market Wire

BioReference to Launch Groundbreaking Solid Tumor .. ping Test through its GenPath Oncology Laboratory

[ Thu, Jan 26th 2012 ] - Market Wire

Study Highlights CyberKnife SBRT Benefits for Treatment of Central Lung Tumors

[ Thu, Jan 26th 2012 ] - Market Wire

Merck to Hold 2011 Full-Year and Fourth-Quarter Sales and Earnings Conference Call on February 2

[ Thu, Jan 26th 2012 ] - Market Wire

Lo studio ASCEND valuter l'efficacia di TYSABRI ( .. o per la sclerosi multipla secondariamente progre

[ Thu, Jan 26th 2012 ] - Market Wire

tude ASCEND pour valuer l'efficacit de TYSABRI (n .. ement pour la sclrose en plaques progressive seco

[ Thu, Jan 26th 2012 ] - Market Wire

ASCEND-Studie zur Prfung der Wirksamkeit von TYSA .. herapie fr sekundr-progrediente Multiple Sklerose

[ Thu, Jan 26th 2012 ] - Market Wire

ASCEND Study to Evaluate the Effectiveness of TYS .. ment for Secondary-Progressive Multiple Sclerosis

[ Thu, Jan 26th 2012 ] - Market Wire

Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimeras Care

[ Thu, Jan 26th 2012 ] - Market Wire

NBA, American Diabetes Association and Sanofi US Tip Off 2012 Dribble to Stop Diabetes Campaign

[ Thu, Jan 26th 2012 ] - Market Wire

Celgene to Acquire Avila Therapeutics

[ Thu, Jan 26th 2012 ] - Market Wire

Auxilium Pharmaceuticals, Inc. Announces First Patients Dosed in XIAFLEX Phase Ib Cellulite Study

[ Thu, Jan 26th 2012 ] - Market Wire

Nutraceutical Reports Fiscal 2012 Q1 Results

[ Thu, Jan 26th 2012 ] - Market Wire

Soligenix Receives $574,000 in Non-Dilutive Finan .. hnology Business Tax Certificate Transfer Program

[ Thu, Jan 26th 2012 ] - Market Wire

Initial Clinical Data Reveal Potential of Tasimel .. the Body Clock in Non-24-Hour Sleep-Wake Disorder

[ Thu, Jan 26th 2012 ] - Market Wire

Illumina Adopts Stockholder Rights Agreement

Wed, January 25, 2012

[ Wed, Jan 25th 2012 ] - Market Wire

Faruqi & Faruqi, LLP Announces Investigation of TranS1 Inc.

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead start een Fase 2 klinisch onderzoek voor d .. n lage-dosis nieuwe prodrug van Tenofovir voor de

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead avvia una sperimentazione clinica di Fase .. 340, un nuovo profarmaco di tenofovir a basso dos

[ Wed, Jan 25th 2012 ] - Market Wire

Law Firm Brower Piven Announces Investigation in .. e Possible Acquisition of Illumina, Inc. by Roche

[ Wed, Jan 25th 2012 ] - Market Wire

Gilead inicia ensayo clnico de Fase 2 que evala G .. e baja dosis de tenofovir para el tratamiento del

[ Wed, Jan 25th 2012 ] - Market Wire

Harwood Feffer LLP Announces Investigation of Illumina Inc.

[ Wed, Jan 25th 2012 ] - Market Wire

Thoratec Schedules Fourth Quarter Conference Call, Webcast

[ Wed, Jan 25th 2012 ] - Market Wire

Investigation of Chemed Corporation Shareholder Claims by Goldfarb Branham Law Firm LLP

[ Wed, Jan 25th 2012 ] - Market Wire

ZELTIQ spant rechtszaak aan tegen Clinipro wegens patentinbreuk

[ Wed, Jan 25th 2012 ] - Market Wire

Neurocrine Biosciences Announces The FDA Has Gran .. t Track Designation For VMAT2 Inhibitor NBI-98854

[ Wed, Jan 25th 2012 ] - Market Wire

Medtronic and Guided Therapeutics Poised for Growth

[ Wed, Jan 25th 2012 ] - Market Wire

Antares Pharma and Boston Scientific Benefit From Renewed Industry Optimism

[ Wed, Jan 25th 2012 ] - Market Wire

Digirad Receives CE Mark Approval for Advanced, Solid-State Cardius(R) X-ACT Imaging System

[ Wed, Jan 25th 2012 ] - Market Wire

ZELTIQ Initiates Patent Infringement Lawsuit Against Clinipro

[ Wed, Jan 25th 2012 ] - Market Wire

Dados Clnicos para o Estudo da DURABILIDADE II Apresentado na ISET 2012

[ Wed, Jan 25th 2012 ] - Market Wire

Donnes cliniques pour l'tude DURABILITY II prsente lors de l'ISET 2012

[ Wed, Jan 25th 2012 ] - Market Wire

FDA actualiseert TYSABRI (natalizumab) label en v .. s antilichaam status toe als een PML risicofactor

[ Wed, Jan 25th 2012 ] - Market Wire

Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508

[ Wed, Jan 25th 2012 ] - Market Wire

DaVita Acquires Majority Stake in NephroLife India

[ Wed, Jan 25th 2012 ] - Market Wire

Cord Blood America Reports that Umbilical Cord Bl .. Used in Experimental Effort to Treat Type 1 Diabe

Tue, January 24, 2012

[ Tue, Jan 24th 2012 ] - Market Wire

Quarterly Report I 11/12

[ Tue, Jan 24th 2012 ] - Market Wire

Codexis Announces CFO Departure

[ Tue, Jan 24th 2012 ] - Market Wire

Mylan to Host Investor Day on Feb. 21, 2012, in New York City

[ Tue, Jan 24th 2012 ] - Market Wire

Radient Pharmaceuticals Introduces its 2012 Sales .. vertising amp;; Outreach Plan Presentation

[ Tue, Jan 24th 2012 ] - Market Wire

Oramed Pharmaceuticals Granted Australian Patent .. pany's Core Technology in Oral Delivery of Protei

[ Tue, Jan 24th 2012 ] - Market Wire

Natural Alternatives International, Inc. Announce .. rts Holdings, LLC and Image Sports, LLC For Infri

[ Tue, Jan 24th 2012 ] - Market Wire

Cleveland BioLabs Announces Management Reorganization

[ Tue, Jan 24th 2012 ] - Market Wire

Critical Outcome Technologies Inc. Initiates Preclinical Testing of AML Drug Candidates

[ Tue, Jan 24th 2012 ] - Market Wire

Psychemedics Awarded Patent Fundamental To Hair Analysis Drug Testing

[ Tue, Jan 24th 2012 ] - Market Wire

Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors

[ Tue, Jan 24th 2012 ] - Market Wire

Booming Stem Cell Market Benefits Advanced Cell Technology and Neostem

[ Tue, Jan 24th 2012 ] - Market Wire

Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry

[ Tue, Jan 24th 2012 ] - Market Wire

Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients

[ Tue, Jan 24th 2012 ] - Market Wire

Adipose Stem Cell Heart Attack Trial Data Publish .. College of Cardiology;; Cytori's APOLLO T

[ Tue, Jan 24th 2012 ] - Market Wire

Spectranetics Strengthens Peripheral Vascular Por .. a Partnership to Distribute the TAPASa" Catheter

[ Tue, Jan 24th 2012 ] - Market Wire

BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C

[ Tue, Jan 24th 2012 ] - Market Wire

PDL BioPharma Announces 2012 Regular Quarterly Dividends

[ Tue, Jan 24th 2012 ] - Market Wire

Quest Diagnostics Increases Share Repurchase Authority by $1 Billion

[ Tue, Jan 24th 2012 ] - Market Wire

Covidien verffentlicht klinische Daten ber Plaque-Exzision zur Behandlung kalzifizierter Lsionen

[ Tue, Jan 24th 2012 ] - Market Wire

TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City

Avanir Pharmaceuticals Announces Date of Fiscal 2012 First Quarter Financial Results and Conference Call

_{//health-fitness.news-articles.net/content/2012/ .. arter-financial-results-and-conference-call.html}
^{Published in Health and Fitness on Monday, January 30th 2012 at 5:41 GMT by Market Wire}

Avanir Pharmaceuticals Announces Date of Fiscal 2012 First Quarter Financial Results... -- ALISO VIEJO, Calif., Jan. 30, 2012 /PRNewswire/ --

Avanir Pharmaceuticals Announces Date of Fiscal 2012 First Quarter Financial Results and Conference Call

[ ]

ALISO VIEJO, Calif., Jan. 30, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: [ AVNR ]) will report financial results for the quarter ended December 31, 2011 after market close on Tuesday February 7, 2012. The company will conduct a conference call and an audio webcast at 1:30 pm Pacific Time (4:30 pm Eastern Time) on the same day.

Conference Call Information:
Domestic callers: 1 (877) 558-3407
International callers: +1 (706) 679-1941
Passcode: 46723714

Webcast information: Visit [ http://www.avanir.com ].

A webcast replay will be available on the Avanir Web site for 30 days. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1 (855) 859-2056 for domestic callers, or +1 (404) 537-3406 for international callers, and entering reservation code 46723714.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit [ www.avanir.com ].

AVANIR® is a registered trademark owned by Avanir Pharmaceuticals, Inc.

©2012 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Avanir Investor & Media Contact
Ian Clements, PhD
[ ir@avanir.com ]
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.avanir.com ]

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire